Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 127

    1.

    Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans.

    Hallschmid M, Randeva H, Tan BK, Kern W, Lehnert H.

    Diabetes. 2009 Mar;58(3):637-40. Epub 2008 Dec 18.PMID: 19095760 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.

    Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M.

    Diabetes. 2005 Oct;54(10):2911-6.PMID: 16186392 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.

    de Boer JF, Bahr MJ, Böker KH, Manns MP, Tietge UJ.

    Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G196-201. Epub 2008 Dec 12.PMID: 19074645 [PubMed - indexed for MEDLINE]Related articles

    4.

    Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.

    Malavazos AE, Ermetici F, Cereda E, Coman C, Locati M, Morricone L, Corsi MM, Ambrosi B.

    Nutr Metab Cardiovasc Dis. 2008 Oct;18(8):523-30. Epub 2008 Feb 20.PMID: 18083357 [PubMed - indexed for MEDLINE]Related articles

    5.

    Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.

    Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ.

    J Clin Endocrinol Metab. 2006 Jan;91(1):295-9. Epub 2005 Oct 18.PMID: 16234302 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of exercise training on plasma visfatin and eotaxin levels.

    Choi KM, Kim JH, Cho GJ, Baik SH, Park HS, Kim SM.

    Eur J Endocrinol. 2007 Oct;157(4):437-42.PMID: 17893257 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices.

    Davutoglu M, Ozkaya M, Guler E, Garipardic M, Gursoy H, Karabiber H, Kilinc M.

    Swiss Med Wkly. 2009 Jan 10;139(1-2):22-7.PMID: 19142752 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile.

    Wang P, van Greevenbroek MM, Bouwman FG, Brouwers MC, van der Kallen CJ, Smit E, Keijer J, Mariman EC.

    Pflugers Arch. 2007 Sep;454(6):971-6. Epub 2007 Apr 12.PMID: 17429683 [PubMed - indexed for MEDLINE]Related articles

    9.

    Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

    Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.

    Am J Kidney Dis. 2007 Feb;49(2):237-44.PMID: 17261426 [PubMed - indexed for MEDLINE]Related articles

    10.

    The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.

    Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT.

    J Clin Endocrinol Metab. 1997 Apr;82(4):1293-300.PMID: 9100610 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.

    Chen CC, Li TC, Li CI, Liu CS, Lin WY, Wu MT, Lai MM, Lin CC.

    Metabolism. 2007 Sep;56(9):1216-20.PMID: 17697864 [PubMed - indexed for MEDLINE]Related articles

    12.

    Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.

    Filippatos TD, Derdemezis CS, Kiortsis DN, Tselepis AD, Elisaf MS.

    J Endocrinol Invest. 2007 Apr;30(4):323-6.PMID: 17556870 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.

    Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, Milan G, Rossato M, Federspil G, Vettor R.

    J Clin Endocrinol Metab. 2006 Aug;91(8):3165-70. Epub 2006 May 23.PMID: 16720654 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.

    Marcinkowska M, Lewandowski KC, Lewiński A, Bieńkiewicz M, Basińska-Lewandowska M, Salata I, Randeva HS.

    Endokrynol Pol. 2007 May-Jun;58(3):188-94.PMID: 17940983 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.

    de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Romero E.

    Nutrition. 2008 Jun;24(6):517-21. Epub 2008 Mar 17.PMID: 18343636 [PubMed - indexed for MEDLINE]Related articles

    16.

    Circulating visfatin level is correlated with inflammation, but not with insulin resistance.

    Oki K, Yamane K, Kamei N, Nojima H, Kohno N.

    Clin Endocrinol (Oxf). 2007 Nov;67(5):796-800. Epub 2007 Jul 18.PMID: 17634078 [PubMed - indexed for MEDLINE]Related articles

    17.

    Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians.

    Sandeep S, Velmurugan K, Deepa R, Mohan V.

    Metabolism. 2007 Apr;56(4):565-70.PMID: 17379018 [PubMed - indexed for MEDLINE]Related articles

    18.

    The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.

    Jian WX, Luo TH, Gu YY, Zhang HL, Zheng S, Dai M, Han JF, Zhao Y, Li G, Luo M.

    Diabet Med. 2006 Sep;23(9):967-73.PMID: 16922702 [PubMed - indexed for MEDLINE]Related articles

    19.

    Visfatin expression is elevated in normal human pregnancy.

    Morgan SA, Bringolf JB, Seidel ER.

    Peptides. 2008 Aug;29(8):1382-9. Epub 2008 Apr 26.PMID: 18524416 [PubMed - indexed for MEDLINE]Related articles

    20.

    Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.

    Araki S, Dobashi K, Kubo K, Kawagoe R, Yamamoto Y, Kawada Y, Asayama K, Shirahata A.

    Obesity (Silver Spring). 2008 Feb;16(2):384-8.PMID: 18239648 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data